Help Lines 954-785-1121
 


You are not logged in. Upgrade Here
 <<<Previous Mid Day Report     Next Mid Day Report >>> 
 <<<Previous After Market Report Next After Market Report >>> 
You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Monday, February 26, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

 MIDDAY BREAKOUTS REPORT - WEDNESDAY, JULY 13TH, 2022
Previous Mid Day Report Next Mid Day Report >>>

DOW 30797.82 -183.51 (-0.59%) | NASDAQ 11233.55 -31.18 (-0.28%) | S&P 500 3801.02 -17.78 (-0.47%)
Time of Screening : 7/13/2022 12:33:19 PM         Report Released : 7/13/2022 1:08:15 PM
Price is: Above 52W High and Less Than 52W High but within 15% of the 52 Week High
Volume Is: At least 45% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page
Symbol/Exchange
Company Name
Industry Group
PRICE CHANGE
(%Change)
Day High Volume
(% DAV)
(50 DAV)
52 Wk Hi
% From Hi
Date
Featured
Price
Featured
Pivot Point
Max Buy
IMXI - NASDAQ
International Money Express
$21.57 -0.45
-2.02%
$21.93 589,956
146.76% of 50 DAV
50 DAV is 402,000
$22.94
-5.99%
7/1/2022 $21.27 PP = $21.38
MB = $22.45
Most Recent Note - 7/13/2022 12:52:47 PM
Y - Color code is changed to yellow while pulling back below its "max buy" level enduring distributional pressure, yet it has rebounded from early lows. Its 50 DMA line ($20.25) defines important near-term support to watch. Fundamentals through the Mar '22 quarter have been strong.
>>> The latest Featured Stock Update with an annotated graph appeared on 7/1/2022. Click here.
View all notes | Alert me of new notes | Company Profile | SEC | News | ChartC A N S L I M

Symbol - Exchange - Industry Group
Company Name
Last Chg Day
High
52 WK Hi % From Hi Volume
% DAV
DAV
AZN - NYSE - DRUGS - Drug Manufacturers - Major
Astrazeneca Plc Ads
$66.45 -0.27
-0.40%
$66.64 $71.70 -7.32% 3,454,556
49.58%
6,968,000
Most Recent Note for AZN - 7/13/2022 12:34:11 PM
Consolidating above its 50 DMA line after finding support near its 200 DMA line. Little resistance remains due to overhead supply up to the $71 level. Prior mid-day reports noted - "Prior quarterly and annual earnings history is not a match with the fundamental guidelines of the fact-based investment system."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
CAPL - NYSE - Oil&Gas-Refining/Mktg
CrossAmerica Partners LP
$20.09 -0.02
-0.10%
$20.17 $23.29 -13.74% 51,173
106.61%
48,000
Most Recent Note for CAPL - 7/13/2022 12:35:18 PM
Pulled back from near its 52-week high with volume-driven losses, slumping below its 50 and 200 DMA lines. Prior mid-day reports cautioned members - "Fundamental concerns remain."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
ECPG - NASDAQ - FINANCIAL SERVICES - Credit Services
Encore Capital Group Inc
$64.08 +1.34
2.14%
$64.52 $72.67 -11.82% 276,632
95.72%
289,000
Most Recent Note for ECPG - 7/13/2022 12:40:19 PM
Reported the Mar '22 quarter with strong +115% earnings on +20% sales revenues versus the year ago period. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria).
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
GIB - NYSE - Computer - Tech Services
CGI Inc Cl A
$82.26 +0.93
1.14%
$82.50 $93.93 -12.42% 78,738
48.01%
164,000
Most Recent Note for GIB - 7/13/2022 12:41:41 PM
Reported earnings +7% on +5% sales revenues for the Mar '22 quarter versus the year ago period. Fundamental concerns remain. Sub par sales revenues and earnings growth leaves concerns with respect to the winning models of the fact-based investment system.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
GSK - NYSE - Medical-Diversified
Glaxosmithkline Plc Adr
$40.96 -0.48
-1.15%
$41.11 $46.97 -12.79% 5,817,401
98.15%
5,927,000
Most Recent Note for GSK - 7/13/2022 12:43:20 PM
Slumping further below its 200 DMA line again with today's 3rd consecutive loss. Recently met resistance near its 50 DMA line. Prior mid-day reports noted - "UK-based pharmaceuticals firm's quarterly comparisons through Mar '22 have not shown strong and steady earnings increases above the +25% minimum guideline (C criteria). Annual earnings (A criteria) history is not a match with the fact-based investment system's fundamental guidelines."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
GWW - NYSE - WHOLESALE - Electronics Wholesale
Grainger W W Inc
$458.86 -15.31
-3.23%
$464.65 $529.91 -13.41% 245,335
80.97%
303,000
Most Recent Note for GWW - 7/13/2022 12:46:32 PM
Gapped down today. Slumped below its 200 DMA line ($480) in recent weeks then met resistance there when rebounding. Noted with caution in the 4/14/22 mid-day report after wedging to new all-time highs with gains lacking great volume conviction. Reported earnings +58% on +18% sales revenues for the quarter ended March 31, 2022 versus the year ago period marking its 3rd consecutive quarterly comparison above the minimum +25% earnings guideline (C criteria). The annual earnings history for this Retail/Wholesale Building Products firm has been up and down which raises concerns with respect to the A criteria of the fact-based investment system's guidelines.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
HURN - NASDAQ - DIVERSIFIED SERVICES - Business/Management Services
Huron Consulting Grp Inc
$62.54 -0.40
-0.63%
$62.70 $66.12 -5.42% 328,256
185.46%
177,000
Most Recent Note for HURN - 7/13/2022 12:48:58 PM
Pulled back from multi-year highs testing support at its 50 DMA line ($59.45) today yet managed a "positive reversal" from early lows. Prior mid-day reports noted - "Reported earnings +40% on +29% sales revenues for the quarter ended March 31, 2022 versus the year ago period, its 3rd consecutive quarterly comparison above the +25% minimum earnings guideline (C criteria). Up and down annual earnings (A criteria) history is not a good match with the guidelines of the fact-based system. It survived but failed to impress since dropped from the Featured Stocks list on 8/15/2007."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
SYBT - NASDAQ - Banks-Southeast
S Y Bancorp Inc
$60.60 -1.21
-1.96%
$61.81 $67.40 -10.09% 57,239
53.49%
107,000
Most Recent Note for SYBT - 7/13/2022 12:53:08 PM
Quarterly and annual earnings history (C and A criteria) is not a match with the fact-based investment system's fundamental guidelines.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
TAP - NYSE - Beverages-Alcoholic
Molson Coors Brewing B
$58.08 +0.68
1.18%
$58.37 $57.75 0.56% 934,988
59.03%
1,584,000
Most Recent Note for TAP - 7/13/2022 1:04:59 PM
Today's 4th consecutive gain has it rallying above recent highs and toward its 52-week high. Reported strong Dec '21 and Mar '22 quarterly results versus the year ago periods. Prior quarterly and annual earnings history (C and A criteria) has been lackluster and is not a match with the fundamental guidelines of the fact-based investment system.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
USAK - NASDAQ - TRANSPORTATION - Trucking
U S A Truck Inc
$31.15 -0.11
-0.35%
$31.31 $31.67 -1.64% 124,908
45.75%
273,000
Most Recent Note for USAK - 7/13/2022 1:06:45 PM
Holding its ground after a gap up on 6/24/22 M&A news. Recent quarterly comparisons through Mar '22 were strong but its prior earnings history is not a match with the fundamental guidelines of the fact-based investment system.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  

THESE ARE NOT BUY RECOMMENDATIONS!  Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time.  Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

 We appreciate any feedback members may wish to send via the inquiry form here.

Kenneth J. Gruneisen founded Gruneisen Growth Corp. (2003), which prior to May 11, 2015, operated CANSLIM.net and CANSLIM.com both under license from Data Analysis Inc. / Investor's Business Daily. Kenneth has passed the CAN SLIM® Master's Exam. Gruneisen Growth Corp. now continues over two decades of fact based market analysis via FactBasedInvesting.com.

Copyright © 1996-2024 Gruneisen Growth Corp. All rights reserved. Protected by the copyright laws of the United States and Canada and by international treaties

Privacy Policy | Terms of Use | Contact Us